|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
107,850,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Vaxcyte is a clinical-stage vaccine company. Co. is developing conjugate and protein vaccines to treat bacterial infectious diseases. Co.'s primary vaccine candidate, VAX-24, is a 24-valent investigational pneumococcal conjugate vaccine (PCV) for the treatment of invasive pneumococcal disease and pneumonia. Co.'s second PCV candidate, VAX-XP, is designed to expand the breadth of coverage to greater than 30 strains without compromising immunogenicity due to carrier suppression. In addition, Co.'s pipeline includes VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep and VAX-PG, a protein vaccine candidate targeting the keystone pathogen responsible for periodontitis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
132,527 |
297,711 |
366,947 |
577,759 |
| Total Sell Value |
$9,422,498 |
$19,561,310 |
$23,008,468 |
$28,538,885 |
| Total People Sold |
5 |
6 |
6 |
8 |
| Total Sell Transactions |
17 |
37 |
45 |
83 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pickering Grant |
Chief Executive Officer |
• • – |
2022-03-21 |
4 |
OE |
$1.79 |
$25,576 |
D/D |
14,288 |
718,182 |
|
- |
|
| Guggenhime Andrew |
President and CFO |
• – – |
2022-03-18 |
4 |
AS |
$26.13 |
$80,993 |
D/D |
(3,100) |
40,625 |
|
- |
|
| Guggenhime Andrew |
President and CFO |
• – – |
2022-03-18 |
4 |
OE |
$5.35 |
$16,585 |
D/D |
3,100 |
43,725 |
|
- |
|
| Fairman Jeff |
VP, Research |
• – – |
2022-03-11 |
4 |
AS |
$25.50 |
$255,000 |
I/I |
(10,000) |
331,227 |
|
- |
|
| Sauer Paul |
SVP Process Dev, Manufacturing |
• – – |
2022-03-10 |
4 |
AS |
$25.00 |
$150,000 |
D/D |
(6,000) |
31,125 |
|
- |
|
| Wassil Jim |
Chief Operating Officer |
• – – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
42,944 |
|
- |
|
| Pickering Grant |
Chief Executive Officer |
• • – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
71,875 |
703,894 |
|
- |
|
| Sauer Paul |
SVP Process Dev, Manufacturing |
• – – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
37,125 |
|
- |
|
| Guggenhime Andrew |
President and CFO |
• – – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
40,625 |
|
- |
|
| Dhaliwal Harpreet S. |
SVP Cml Mfg & Supply Chain |
• – – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
17,500 |
|
- |
|
| Fairman Jeff |
VP, Research |
• – – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
16,629 |
|
- |
|
| Guggenhime Andrew |
President and CFO |
• – – |
2022-03-01 |
4 |
AS |
$24.00 |
$148,800 |
D/D |
(6,200) |
3,125 |
|
- |
|
| Guggenhime Andrew |
President and CFO |
• – – |
2022-03-01 |
4 |
OE |
$5.35 |
$33,170 |
D/D |
6,200 |
9,325 |
|
- |
|
| Wassil Jim |
Chief Operating Officer |
• – – |
2022-02-24 |
4 |
AS |
$22.00 |
$220,000 |
D/D |
(10,000) |
17,944 |
|
- |
|
| Wassil Jim |
Chief Operating Officer |
• – – |
2022-02-24 |
4 |
OE |
$2.42 |
$24,200 |
D/D |
10,000 |
27,944 |
|
- |
|
| Sauer Paul |
SVP Process Dev, Manufacturing |
• – – |
2021-12-29 |
4 |
AS |
$25.00 |
$150,000 |
D/D |
(6,000) |
27,125 |
|
- |
|
| Fairman Jeff |
VP, Research |
• – – |
2021-12-27 |
4 |
AS |
$23.58 |
$112,093 |
D/D |
(4,750) |
6,160 |
|
- |
|
| Fairman Jeff |
VP, Research |
• – – |
2021-12-27 |
4 |
OE |
$1.79 |
$8,503 |
D/D |
4,750 |
10,910 |
|
- |
|
| Pickering Grant |
Chief Executive Officer |
• • – |
2021-12-27 |
4 |
OE |
$1.79 |
$92,995 |
D/D |
51,765 |
632,019 |
|
- |
|
| Guggenhime Andrew |
President and CFO |
• – – |
2021-12-23 |
4 |
AS |
$24.00 |
$74,400 |
D/D |
(3,100) |
3,125 |
|
- |
|
| Guggenhime Andrew |
President and CFO |
• – – |
2021-12-23 |
4 |
OE |
$5.35 |
$16,585 |
D/D |
3,100 |
6,225 |
|
- |
|
| Fairman Jeff |
VP, Research |
• – – |
2021-12-20 |
4 |
OE |
$1.79 |
$8,000 |
D/D |
4,469 |
10,629 |
|
- |
|
| Fairman Jeff |
VP, Research |
• – – |
2021-12-16 |
4 |
AS |
$22.50 |
$103,928 |
D/D |
(4,619) |
6,160 |
|
- |
|
| Fairman Jeff |
VP, Research |
• – – |
2021-12-16 |
4 |
OE |
$1.79 |
$8,268 |
D/D |
4,619 |
10,779 |
|
- |
|
| Fairman Jeff |
VP, Research |
• – – |
2021-12-09 |
4 |
AS |
$22.50 |
$2,948 |
D/D |
(131) |
6,160 |
|
- |
|
349 Records found
|
|
Page 9 of 14 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
